Research Lab Results for genetics
Brain Tumor Cancer Genetics LabLab WebsitePrincipal Investigator:
Chetan Bettegowda, M.D., Ph.D.
The lab explores the genetic underpinnings that drive the pathogenesis of a variety of primary ...central nervous system neoplasms. We are interested in exploiting genetic changes for both diagnostic and therapeutic purposes. Our lab is currently working on understanding the extreme responders and extreme clinical phenotypes of brain and spinal cord tumors to identify factors that may modulate responses to therapy. view moreResearch Areas: brain tumor genetics, brain tumor
Brain Tumor LaboratoryLab WebsitePrincipal Investigator:
Henry Brem, M.D.
At the brain tumor laboratory, Henry Brem, M.D. and Betty Tyler, along with more than 350 train...ees, have conducted scientific research, contributed to scientific literature, amended clinical practice, and illuminated new pathways for improving clinical outcomes.Research Areas: brain tumor drug delivery, brain tumor
The laboratory has advanced the understanding of gene therapy, angiogenesis, intracranial implantation of biodegradable polymers to treat malignant glioma, tumor genetics and proteomics, microchip drug delivery and drug resistance studies. Dr. Brem and his colleagues have designed and led many multi-institutional clinical trials to improve and expand the range of therapeutic options for patients with brain tumors. view more
Dhananjay Vaidya LabPrincipal Investigator:
Jay Vaidya, M.B.B.S., Ph.D., M.P.H.
Research conducted in the Dhananjay Vaidya Lab focuses on the prevention of heart disease, with... special emphasis on cardiometabolic risk factors, genetics in high-risk families, cardiovascular epidemiology, statistics and vascular biology. We also provide consultation on study design as well as plan and oversee data analyses for projects supported by the Center for Child and Community Health Research. view moreResearch Areas: heart disease, epidemiology, data analysis, cardiometabolic risk factors, statistics, study design, cardiovascular, genomics, vascular biology
DNA Diagnostic LabLab WebsitePrincipal Investigator:
Garry Cutting, M.D.
Established in 1979, the Johns Hopkins DNA Diagnostic Laboratory is a CLIA and CAP certified; M...aryland, New York, and Pennsylvania licensed clinical genetics testing laboratory specializing in rare inherited disorders. Led by renown professor of pediatrics and medical genetics Dr. Garry R. Cutting, the lab offers testing for a range of approximately 50 phenotypes and disorders totaling 3,500 tests annually. view moreResearch Areas: genetics, genetic sequencing, genetic counseling, rare inherited disorders
Dong LaboratoryLab WebsitePrincipal Investigator:
Xinzhong Dong, Ph.D.
The Dong Laboratory has identified many genes specifically expressed in primary sensory neurons... in dorsal root ganglia (DRG). Our lab uses multiple approaches, including molecular biology, mouse genetics, mouse behavior and electrophysiology, to study the function of these genes in pain and itch sensation. Other research in the lab examines the molecular mechanism of how skin mast cells sensitize sensory nerves under inflammatory states. view moreResearch Areas: skin cells, electrophysiology, genetics, itch, neuroscience, pain, molecular biology
Early Detection of Pancreatic Cancer LaboratoryPrincipal Investigator:
Michael Goggins, M.B.B.Ch., M.D.
The goal of the lab's research is to identify molecular abnormalities that can improve the outc...ome of patients with pancreatic cancer and those at risk of developing this disease. Much of our work is focused on translational research evaluating markers and marker technologies that can help screen patients with an increased risk of developing pancreatic cancer.Research Areas: pancreatic cancer
Thus, marker efforts have been focused mostly on identifying markers of advanced precancerous neoplasia (PanINs and IPMNs) that could improve our ability to effectively screen patients at risk of developing pancreatic cancer. We lead or participate in a number of clinical research protocols involved in the screening and early detection of pancreatic neoplasia including the CAPS clinical trials. We maintain a large repository of specimens from cases and controls with and without pancreatic disease and use this repository to investigate candidate markers of pancreatic cancer for their utility to predict pancreatic cancer risk.
In addition, we have been working to identify familial pancreatic cancer susceptibility genes and identified BRCA2 as a pancreatic cancer susceptibility gene in 1996. We participate in the PACGENE consortium and the familial pancreatic cancer sequencing initiative. My lab also investigates pancreatic cancer genetics, epigenetics, molecular pathology, tumor stromal interactions and functional analysis of candidate genes and miRNAs. Dr. Goggins is the principal investigator of a phase I/II clinical trial evaluating the Parp inhibitor, olaparib along with irinotecan and cisplatin for patients with pancreatic cancer. view more
GI Early Detection Biomarkers LabPrincipal Investigator:
Stephen Meltzer, M.D.
Dr. Meltzer is an internationally renowned leader in the molecular pathobiology of gastrointest...inal malignancy and premalignancy. He invented molecular methods to detect loss of heterozygosity in tiny biopsies, triggering an avalanche of research on precancerous lesions. He was the first to comprehensively study coding region microsatellite instability, leading to the identification of several important tumor suppressor genes. He performed several groundbreaking genomic, epigenomic and bioinformatic studies of esophageal and colonic neoplasms, shifting the GI research paradigm toward genome-wide approaches. He directed an ambitious nationwide validation study of DNA methylation-based biomarkers for the prediction of neoplastic progression in Barrett’s esophagus.Research Areas: gastrointestinal cancer, gastrointestinal
Dr. Meltzer founded and led the Aerodigestive Cancer and Biomarker Interdisciplinary Programs at the University of Maryland, also becoming associate director for core sciences at that school’s Cancer Center. He currently holds an endowed professorship and is the director of GI biomarker research at Johns Hopkins.
The laboratory group focuses its efforts on the molecular genetics of gastrointestinal cancers and premalignant lesions, as well as on translational research to improve early detection, prognostic evaluation, and treatment of these conditions. Below, some examples of this work are described. view more
Huang LaboratoryLab WebsitePrincipal Investigator:
Chuan-Hsiang Huang, M.D., Ph.D.
Our lab is interested in understanding the fundamental mechanisms of how cells move and implica...tions in disease treatment. We use an interdisciplinary approach involving fluorescent live cell imaging, genetics, and computer modeling to study the systems level properties of the biochemical networks that drive cell migration. view moreResearch Areas: pathology
Joseph Mankowski LabPrincipal Investigator:
Joseph L. Mankowski, D.V.M., Ph.D.
Molecular and Comparative Pathobiology
The Joseph Mankowski Lab studies the immunopathogenesis of HIV infection using the SIV/macaque ...model. Our researchers use a multidisciplinary approach to dissect the mechanism underlying HIV-induced nervous system and cardiac diseases. Additionally, we study the role that host genetics play in HIV-associated cognitive disorders. view moreResearch Areas: macaques, HIV, genomics, SIV, pathogenesis, cardiology, nervous system
Ken Hui LabPrincipal Investigator:
Ken Hui, M.D., Ph.D.
The Hui lab performs basic, translational and clinical research on genetics and genomics of neu...rogastroenterological disorders.Research Areas: Genetics and genomics of neurogastroenterological disorders
Kenneth W. Kinzler LaboratoryLab WebsitePrincipal Investigator:
Kenneth Kinzler, Ph.D.
Dr. Kinzler’s laboratory has focused on the genetics of human cancer. They have identified a va...riety of genetic mutations that underlie cancer, including mutations of the APC pathway that appear to initiate the majority of colorectal cancers and IDH1/2 mutations that underlying many gliomas. In addition, they have developed a variety of powerful tools for analysis of expression and genetic alterations in cancer.Research Areas: cancer, molecular genetics
Most recently, they have pioneered integrated whole genome analyses of human cancers through expression, copy number, and mutational analyses of all the coding genes in several human cancer types including colorectal, breast, pancreatic and brain. The identification of genetic differences between normal and tumor tissues provide new therapeutic targets, new opportunities for the early diagnosis of cancer, and important insights into the neoplastic process. view more
Li Gao LabPrincipal Investigator:
Li Gao, M.D., Ph.D.
The Li Gao Lab researches functional genomics, molecular genetics and epigenetics of complex ca...rdiopulmonary and allergic diseases, with a focus on translational research applying fundamental genetic insight into the clinical setting. Current research includes implementation of high-throughput technologies in the fields of genome-wide association studies (GWAS), massively parallel sequencing, gene expression analysis, epigenetic mapping and integrative genomics in ongoing research of complex lung diseases and allergic diseases including asthma, atopic dermatitis (AD), pulmonary arterial hypertension, COPD, sepsis and acute lung injury/ARDS; and epigenetic contributions to pulmonary arterial hypertension associated with systemic sclerosis. view moreResearch Areas: pulmonary arterial hypertension, molecular genetics, cardiopulmonary diseases, asthma, epigenetics, complex lung disease, allergies, genomics, COPD, atopic dermatitis
Michael Caterina LabPrincipal Investigator:
Michael Caterina, M.D., Ph.D.
The Caterina lab is focused on dissecting mechanisms underlying acute and chronic pain sensatio...n. We use a wide range of approaches, including mouse genetics, imaging, electrophysiology, behavior, cell culture, biochemistry and neuroanatomy to tease apart the molecular and cellular contributors to pathological pain sensation. A few of the current projects in the lab focus on defining the roles of specific subpopulations of neuronal and non-neuronal cells to pain sensation, defining the role of RNA binding proteins in the development and maintenance of neuropathic pain, and understanding how rare skin diseases known as palmoplantar keratodermas lead to severe pain in the hands and feet. view moreResearch Areas: biophysics, biochemistry, proteomics, inflammation, pain
Molecular Genetics Laboratory of Female Reproductive CancerLab WebsitePrincipal Investigator:
Tian-Li Wang, Ph.D.
The long-term objectives of our research team are:Research Areas: genetics, diagnostic pathology, ovarian cancer, gestational trophoblastic diseases
a. to understand the molecular etiology ...in the development of human cancer, and
b. to identify and characterize cancer molecules for cancer detection, diagnosis, and therapy.
We use ovarian carcinoma as a disease model because it is one of the most aggressive neoplastic diseases in women. For the first research direction, we aim to identify and characterize the molecular alterations during initiation and progression of ovarian carcinomas. view more
O'Connor LabLab WebsitePrincipal Investigator:
Daniel O'Connor, Ph.D., M.A.
How do brain dynamics give rise to our sensory experience of the world? The O'Connor lab works ...to answer this question by taking advantage of the fact that key architectural features of the mammalian brain are similar across species. This allows us to leverage the power of mouse genetics to monitor and manipulate genetically and functionally defined brain circuits during perception. We train mice to perform simple perceptual tasks. By using quantitative behavior, optogenetic and chemical-genetic gain- and loss-of-function perturbations, in vivo two-photon imaging, and electrophysiology, we assemble a description of the relationship between neural circuit function and perception. We work in the mouse tactile system to capitalize on an accessible mammalian circuit with a precise mapping between the sensory periphery and multiple brain areas. Our mission is to reveal the neural circuit foundations of sensory perception; to provide a framework to understand how circuit dysfunction causes mental and behavioral aspects of neuropsychiatric illness; and to help others fulfill creative potential and contribute to human knowledge. view moreResearch Areas: brain, mental illness, neuroscience, perception
Rasika Mathias LabPrincipal Investigator:
Rasika Mathias, Sc.D.
Research in the Rasika Mathias Lab focuses on the genetics of asthma in people of African ances...try. Our work led to the first genomewide association study of its kind in 2009. Currently, we are analyzing the whole-genome sequence of more than 1,000 people of African ancestry from the Consortium on Asthma among African-ancestry Populations in the Americas (CAAPA). CAAPA’s goal is to use whole-genome sequencing to expand our understanding of how genetic variants affect asthma risk in populations of African ancestry and to provide a public catalog of genetic variation for the scientific community. We’re also involved in the study of coronary artery disease though the GeneSTAR Program, which aims to identify mechanisms of atherogenic vascular diseases and attendant comorbidities. view moreResearch Areas: heart disease, African Americans, asthma, genomics, health disparities
Retrovirus LaboratoryPrincipal Investigator:
Janice Clements, Ph.D.
Molecular and Comparative Pathobiology
Research in the Retrovirus Laboratory focuses on the molecular virology and pathogenesis of len...tivirus infections. In particular, we study the simian immunodeficiency virus (SIV) to determine the molecular basis for the development of HIV CNS, pulmonary and cardiac disease.Research Areas: HIV, genomics, pulmonology, SIV, cardiology, lentivirus
Research projects include studies of viral molecular genetics and host cell genes and proteins involved in the pathogenesis of disease. We are also interested in studies of lentivirus replication in macrophages and astrocytes and their role in the development of disease. These studies have led us to identify the viral genes that are important in neurovirulence of SIV and the development of CNS disease including NEF and the TM portion of ENV. The mechanisms of the action of these proteins in the CNS are complex and are under investigation. We have also developed a rapid, consistent SIV/macaque model in which we can test the ability of various antiviral and neuroprotective agents to reduce the severity of CNS and pulmonary disease. view more
Ryuya Fukunaga LabPrincipal Investigator:
Ryuya Fukunaga, Ph.D.
The Fukunaga Lab uses multidisciplinary approaches to understand the cell biology, biogenesis a...nd function of small silencing RNAs from the atomic to the organismal level.Research Areas: biophysics, biochemistry, cell biology, cell culture, genomics, RNA
The lab studies how small silencing RNAs, including microRNAs (miRNAs), small interfering RNAs (siRNAs) and piwi-interacting RNAs (piRNAs), are produced and how they function. Mutations in the small RNA genes or in the genes involved in the RNA pathways cause many diseases, including cancers. We use a combination of biochemistry, biophysics, fly genetics, cell culture, X-ray crystallography and next-generation sequencing to answer fundamental biological questions and also potentially lead to therapeutic applications to human diseases. view more
Shanthini Sockanathan LaboratoryLab WebsitePrincipal Investigator:
Shanthini Sockanathan, D.Phil.
The Shanthini Sockanathan Laboratory uses the developing spinal cord as our major paradigm to d...efine the mechanisms that maintain an undifferentiated progenitor state and the molecular pathways that trigger their differentiation into neurons and glia. The major focus of the lab is the study of a new family of six-transmembrane proteins (6-TM GDEs) that play key roles in regulating neuronal and glial differentiation in the spinal cord. We recently discovered that the 6-TM GDEs release GPI-anchored proteins from the cell surface through cleavage of the GPI-anchor. This discovery identifies 6-TM GDEs as the first vertebrate membrane bound GPI-cleaving enzymes that work at the cell surface to regulate GPI-anchored protein function. Current work in the lab involves defining how the 6-TM GDEs regulate cellular signaling events that control neuronal and glial differentiation and function, with a major focus on how GDE dysfunction relates to the onset and progression of disease. To solve these questions, we use an integrated approach that includes in vivo models, imaging, molecular biology, biochemistry, developmental biology, genetics and behavior. view moreResearch Areas: glia, biochemistry, neurons, imaging, developmental biology, genomics, spinal cord, behavior, molecular biology